Walgreen upgraded to Outperform from Neutral at Macquarie
Macquarie believes downside revisions to Walgreen (WAG) estimates is limited and that a contract resolution with Express Scripts (ESRX) is likely. Price target raised to $38 from $35. :theflyonthewall.com
News For WAG From The Last 14 Days
Check below for free stories on WAG the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
